EU approves Celltrion's COVID-19 antibody treatment

The European Union's drug agency has approved the COVID-19 antibody treatment by Celltrion Inc. This is a milestone for the South Korean pharmaceutical company as it will pave the way for the sale of the treatment in the region.

Highlights

• &nb...

Researchers  develop needle-free Covid-19 vaccine patches 

Scientists have been trying to create patches to deliver life-saving drugs painlessly into the skin. This development could be a revolution in the field of medicine.
 

Highlights
•    Covid-19 patches discovered by researchers...

S. KOREA APPROVES CELLTRION INC.’S COVID-19 ANTIBODY TREATMENT WITH CONDITIONS

Highlights –

• S. Korea approves Celltrion Inc.’s COVID-19 antibody treatment with conditions.
• The country’s drug safety agency has given conditional marketing authorization of CT-P59.
• Celltrion plans to conduct a global pha...

JAPAN HEALTH MINISTRY REPORTS LESS THAN 1% OF PEOPLE HAD COVID-19 ANTIBODIES

Highlights –

• Japan Health Ministry reports less than 1% of people had COVID-19 antibodies.
• The govt. conducted tests of about 15,000 individuals at the end of 2020.
• Five prefectures participated in the antibodies test.
• In T...

AUSTRALIAN GOVERNMENT PLANS $1.9 BILLION FOR VACCINATION AS IT ENDS THE PANDEMIC PAYMENTS

HIGHLIGHTS

• Scott Morrison promised $1.9bn for Australia's antibody rollout and endeavor to reinforce customer certainty while setting up people in general for the withdrawal of financial backings in a scene-setting address in front of the resumption of parli...

JAPAN HEALTH MINISTER ANNOUNCES TO TEST 15,000 PEOPLE FOR COVID-19 ANTIBODY TEST

Highlights –

• Japan health minister announces to test 15,000 people for COVID-19 antibody test.
• The antibody tests will be done by the end of the year.
• The testing will take place in Tokyo, Osaka, and three other prefectures.

FDA PERMITS EMERGENCY USE OF COVID-19 DRUG BY ELI LILLY & CO

Highlights

• Bamlanivimab developed by Eli Lilly & Co was granted emergency use authorization (EUA) by the FDA based on trial data which showcased that a one-time infusion of the treatment was successful in reducing the need for hospitalization

• This drug from E...

KYUSHU UNIVERSITY TO OFFER COVID-19 ANTIBODY TEST KIT THAT USES SILKWORMS

Highlights –

• Kyushu University to offer COVID-19 antibody test kit that uses silkworms.
• Kaico Ltd. and Protects Co. have jointly developed the mail-in kit.
• Each test kit is priced at around 5,000 yen and will take a week to get result...

BRISTOL MYERS SQUIBB ACQUIRES CAMBRIDGE ANTIBODY TECHNOLOGY

Highlights

• Along with the initial payment, the US pharma company will also pay for maintenance, the achievement of development milestones and eventual royalty payments on all antibodies derived from the platform

• This IONTAS’ technology helps bring down the ...

TRIALS BEGIN FOR COVID ANTIBODY DRUG

Highlights:

• The National Institute of Health announced on Tuesday that the trials for the COVID antibody drug will begin.
• There are two trials called ACTIV-2 and ACTIV-3 for both considering the safety and efficacy of an antibody...

SOUTH KOREA TO GET ITS FIRST FDA APPROVED ANTIBODY TEST KIT

Highlights –

• New COVID-19 antibody test kit developed by Plexense Inc.
• The company has demonstrated its test kit well to get FDA approval.
• The company will launch the ACCEL ELISA COVID-19.
• The new test kit was developed wit...

IIBR (ISRAEL) DEVELOPS MONOCLONAL ANTI BODY TO FIGHT COVID19

Highlights:

• IIBR was tasked with finding a vaccine for covid19 by PM Benjamin Netanyahu
• This breakthrough treatment, if it works will be new hope for a covis19 free world

When the whole world is collaborating on research and findings for a vaccine an...

ANTIBODY TESTS SUGGESTS 2.7 MILLION NEW YORKERS ALREADY INFECTED

Highlights

• Governor Andrew M. Cuomo stated that antibody tests are key to reopen the economy

• This antibody tests were done on random 3,000 people in the New York state

Last week New York government had decided to go ahead with sample antibody testing in...

NEW YORK BEGINS AGGRESSIVE COVID-19 ANTIBODY TESTING

Highlights

• State Department of Health will randomly select 3,000 people for tests

• As per officials, around 252,595 cases of COVID-19 have reported from New York alone, while over 18,000 people have already lost their lives due to the virus

In order to r...

Why we don't have an antibody for Lyme illness

Lyme sickness is the most widely recognized vector-borne ailment in the United States, contaminating a huge number of individuals every year. However there's right now no antibody available that can shield people from getting this malady — an answer that would be sought after in high-ha...